Metal Metabolism, Inborn Errors: Clinical Trials

14 trials for Metal Metabolism, Inborn Errors, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 2 withdrawn, 1 recruiting. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 6, Unknown 5, Withdrawn 2, Recruiting 1

Follow Metal Metabolism, Inborn Errors: new trials by email Literature Review of Metal Metabolism, Inborn Errors trials Research Report on Metal Metabolism, Inborn Errors

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitigate Immune-Mediated Loss of Therapeutic Response to Asfotase Alfa (STRENSIQ®) for Hypophosphatasia
methotrexate, rituximab, bortezomib - Hypophosphatasia
Phase 4WithdrawnAlexion Pharmaceuticals, Inc.2026-07-292025-12-18
Analysis of the Effect of Iron Supplements on Iron Deficiency Anemia in Pregnancy
Niferex - Iron Deficiency Anemia of Pregnancy, Iron Storage Disease
Phase 4UnknownQianfoshan Hospital4522023-03-282023-04-07
Gandouling in the Treatment of Wilson's Disease
Gandouling - Wilson's Disease
Phase 4UnknownJun Li2402023-01-012024-02-09
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH
KRN23 - X-linked Hypophosphatemia (XLH)
Phase 4CompletedKyowa Kirin Co., Ltd.282021-11-012024-07-09
Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH
KRN23 - X-linked Hypophosphatemia (XLH)
Phase 4CompletedKyowa Kirin Co., Ltd.182021-09-282024-07-09
Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic Disease
asfotase alfa - Hypophosphatasia
Phase 4WithdrawnAlexion Pharmaceuticals, Inc.2020-04-012020-06-04
Examining the Effect of Burosumab on Muscle Function
Burosumab Injection [Crysvita] - X-linked Hypophosphatemia
Phase 4CompletedYale University102019-11-132023-08-24
Effect of Theophylline in Pseudohypoparathyroidism
Theophylline - PHP Ia, PHP IB
Phase 4RecruitingMassachusetts General Hospital1002019-11-112022-07-22
Burosumab in Children and Adolescents With X-linked Hypophosphatemia
Burosumab Injection - Rare Diseases, X-linked Hypophosphatemia
Phase 4UnknownBicetre Hospital572018-03-182020-06-05
Using Different Doses of Active Vitamin D Combined With Neutral Phosphate in Children With X-linked Hypophosphatemia
Calcitriol - X-linked Hypophosphatemia
Phase 4UnknownPeking Union Medical College Hospital1002017-01-012019-01-30
Study to Assess Long-Term Outcomes of Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
trientine dihydrochloride - Wilson Disease
Phase 4UnknownUnivar BV902016-01-012017-08-23
Post-approval Clinical Study of Asfotase Alfa Treatment for Patients With Hypophosphatasia (HPP) in Japan
Asfotase Alfa - Hypophosphatasia
Phase 4CompletedAlexion Pharmaceuticals, Inc.132015-06-012017-05-08
Efficacy Study in Removing Excess Iron From the Heart
Ferriprox (deferiprone), Desferal (deferoxamine) - Thalassemia Major, Hemosiderosis
Phase 4CompletedApoPharma602002-12-012016-01-05
Study of Zinc for Wilson Disease
zinc acetate - Wilson Disease
Phase 4CompletedNational Center for Research Resources (NCRR)3001993-10-012005-06-24

Narrower conditions

Familial Hypophosphatemic Rickets (5)  ·  Hepatolenticular Degeneration (3)  ·  Hypophosphatasia (3)  ·  Hemochromatosis (2)  ·  Rare Diseases (2)  ·  Bone Diseases (1)  ·  Hemosiderosis (1)  ·  Hyperparathyroidism (1)  ·  Iron Overload (1)  ·  Metabolism, Inborn Errors (1)  ·  Osteomalacia (1)  ·  Pseudohypoparathyroidism (1)  ·  Pseudohypoparathyroidism Type 1C (1)  ·  Rickets (1)  ·  Thalassemia (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (14)  ·  Genetic Diseases, Inborn (14)  ·  Metabolic Diseases (14)  ·  Nutritional and Metabolic Diseases (14)  ·  Metabolism, Inborn Errors (13)  ·  Bone Diseases, Metabolic (7)  ·  Calcium Metabolism Disorders (7)  ·  Musculoskeletal Diseases (7)  ·  Avitaminosis (6)  ·  Bone Diseases (6)  ·  Deficiency Diseases (6)  ·  Malnutrition (6)  ·  Nutrition Disorders (6)  ·  Vitamin D Deficiency (6)

Interventions

burosumab (4)  ·  asfotase alfa (2)  ·  Bortezomib (1)  ·  Calcitriol (1)  ·  Deferiprone (1)  ·  Deferoxamine (1)  ·  Folic Acid (1)  ·  Immunoglobulins, Intravenous (1)  ·  Methotrexate (1)  ·  Niferex (1)  ·  Rituximab (1)  ·  Theophylline (1)  ·  Trientine (1)  ·  Zinc Acetate (1)  ·  gluconic acid (1)

Sponsors

Alexion Pharmaceuticals, Inc. (3)  ·  Kyowa Kirin Co., Ltd. (2)  ·  ApoPharma (1)  ·  Bicetre Hospital (1)  ·  Jun Li (1)  ·  Massachusetts General Hospital (1)  ·  National Center for Research Resources (NCRR) (1)  ·  Peking Union Medical College Hospital (1)  ·  Qianfoshan Hospital (1)  ·  Univar BV (1)  ·  Yale University (1)

Countries

China (5)  ·  United States (3)  ·  Greece (2)  ·  Italy (2)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Antonio Piga, M.D. (1)  ·  George J. Brewer (1)  ·  Karl L Insogna, M.D. (1)  ·  Karl-Heinz Weiss, MD (1)  ·  Kenji Fujita, MD (1)  ·  Markissia Karagiorga, M.D. (1)  ·  Renzo Galanello, M.D. (1)  ·  Vassilis Ladis, M.D. (1)  ·  Zhang Zhiwei, PH.D (1)

Results publications

PMID 35482910, PMID 40104015, PMID 40538652